Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal...
Neoplasm MetastasisLiver3 moreThe purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan
Perception of Cure Among Patients With Metastatic Cancer
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmThis study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.
Whole-body MRI for the Detection of Metastasis
Breast CancerMetastasesDevelop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
CancerMetastasis Lung4 moreThe purpose of this prospective, non-randomized, single-center pilot exploratory study is to investigate whether established circulating tumor cell (CTC) cultures have a similar response to targeted therapy treatment as the in vivo (patients') disease.
Expanded Access to ANG1005 for Individual Patients
Anaplastic AstrocytomaAnaplastic Oligodendroglioma2 moreThis is an expanded access study with ANG1005 treatment for two individual patients from Protocol ANG1005-CLN-03 with WHO Grade III Anaplastic Astrocytoma and WHO Grade III Anaplastic Oligodendroglioma and one individual patient from Protocol ANG1005-CLN-04 with Recurrent Brain Metastases and Leptomeningeal Carcinomatosis.
Managed Access Program to Provide Access to Ribociclib, for Locally Advanced or Metastatic Cancer...
Breast CancerThe purpose of this Managed Access Program (MAP) Cohort Treatment Plan is to provide guidance to the Physician for the treatment and monitoring of patients in the Cohort MAP. The Physician should follow the suggested treatment guidelines. Furthermore, the Physician must comply with the MAP Agreement Letter and applicable local laws and regulations.
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Metastatic CancerImmune-based therapies (vaccines) are a new focus of clinical investigation. These therapies try to assist a patient's immune system (a system in our bodies that protects us against infection) in killing tumors. One form of such therapy is the dendritic cell combined with HER-2/neu (a type of protein over-expressed in some cancers) vaccine. Dendritic cells are immune cells that can tell your immune system to fight infection. In laboratory testing, these cells may also help the immune system attack tumors such as breast, kidney cancer or skin cancer. The purpose of this research study is to determine if it is both possible and safe to administer" this vaccine to patients with any HER2+ cancer.
Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer
CancerThis expanded access protocol was designed to provide TJ004309 in combination with atezolizumab to the remaining three patients with advanced or metastatic cancer who plan to continue with treatment.
Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving...
Solid Tumor Metastatic Cancer Advanced CancerThis EAP was designed to provide TJ210001 to the remaining subjects with relapsed or refractory solid tumors who were enrolled on the parent study, TJ210001STM101 (NCT04678921), and plan to continue with treatment.
the Influence of General Anesthesia on Tumor Metastasis and Recurrence
Tumor Recurrence and MetastasisThe purpose of this study was to investigate whether general anesthesia will affect the postoperative recurrence and metastasis of malignant tumor.